425 related articles for article (PubMed ID: 19414767)
21. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
22. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
[TBL] [Abstract][Full Text] [Related]
23. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
24. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
Grimaldi CM
Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
[TBL] [Abstract][Full Text] [Related]
25. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
[TBL] [Abstract][Full Text] [Related]
26. Follicular exclusion of autoreactive B cells requires FcgammaRIIb.
Paul E; Nelde A; Verschoor A; Carroll MC
Int Immunol; 2007 Apr; 19(4):365-73. PubMed ID: 17307801
[TBL] [Abstract][Full Text] [Related]
27. Alternative mechanisms of receptor editing in autoreactive B cells.
Kalinina O; Doyle-Cooper CM; Miksanek J; Meng W; Prak EL; Weigert MG
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7125-30. PubMed ID: 21471456
[TBL] [Abstract][Full Text] [Related]
28. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction.
Eisenberg R; Choudhury A
Methods Mol Med; 2004; 102():273-84. PubMed ID: 15286390
[TBL] [Abstract][Full Text] [Related]
29. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
[TBL] [Abstract][Full Text] [Related]
30. Production of recombinant Ig molecules from antigen-selected single B cells and restricted usage of Ig-gene segments by anti-D antibodies.
Dohmen SE; Mulder A; Verhagen OJ; Eijsink C; Franke-van Dijk ME; van der Schoot CE
J Immunol Methods; 2005 Mar; 298(1-2):9-20. PubMed ID: 15847793
[TBL] [Abstract][Full Text] [Related]
31. Light chain contribution to specificity in anti-DNA antibodies.
Ibrahim SM; Weigert M; Basu C; Erikson J; Radic MZ
J Immunol; 1995 Sep; 155(6):3223-33. PubMed ID: 7673735
[TBL] [Abstract][Full Text] [Related]
32. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
33. Anti-peripherin B lymphocytes are positively selected during diabetogenesis.
Carrillo J; Puertas MC; Planas R; Pastor X; Alba A; Stratmann T; Pujol-Borrell R; Ampudia RM; Vives-Pi M; Verdaguer J
Mol Immunol; 2008 Jun; 45(11):3152-62. PubMed ID: 18433871
[TBL] [Abstract][Full Text] [Related]
34. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
Pewzner-Jung Y; Simon T; Eilat D
J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
[TBL] [Abstract][Full Text] [Related]
35. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA.
Wellmann U; Werner A; Winkler TH
Eur J Immunol; 2001 Sep; 31(9):2800-10. PubMed ID: 11536179
[TBL] [Abstract][Full Text] [Related]
36. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
[TBL] [Abstract][Full Text] [Related]
37. Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay D; Saunders T; Camper S; Weigert M
J Exp Med; 1993 Apr; 177(4):999-1008. PubMed ID: 8459227
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal anti-DNA antibodies: structure, specificity, and biology.
Marion TN; Krishnan MR; Desai DD; Jou NT; Tillman DM
Methods; 1997 Jan; 11(1):3-11. PubMed ID: 8990083
[TBL] [Abstract][Full Text] [Related]
39. The site and stage of anti-DNA B-cell deletion.
Chen C; Nagy Z; Radic MZ; Hardy RR; Huszar D; Camper SA; Weigert M
Nature; 1995 Jan; 373(6511):252-5. PubMed ID: 7816141
[TBL] [Abstract][Full Text] [Related]
40. Regulation of B cell tolerance by the lupus susceptibility gene Ly108.
Kumar KR; Li L; Yan M; Bhaskarabhatla M; Mobley AB; Nguyen C; Mooney JM; Schatzle JD; Wakeland EK; Mohan C
Science; 2006 Jun; 312(5780):1665-9. PubMed ID: 16778059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
